XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.3
Restatement and Revision of Previously Issued Financial Statements
3 Months Ended
Mar. 31, 2024
Accounting Changes and Error Corrections [Abstract]  
Restatement and Revision of Previously Issued Financial Statements

2. Restatement and Revision of Previously Issued Financial Statements

 

Restatement of Previously Issued Financial Statements: March 31, 2024

 

In connection with the preparation of the Company’s financial statements for the three and nine months ended September 30, 2024, the Company’s management determined that a reclassification was necessary in its previously issued unaudited financial statements, relating solely to the balance sheet, as of March 31, 2024. It was determined that the Company’s deferred commission payable, previously classified as a long term liability, should have been classified as a current liability in the Company’s March 31, 2024 condensed consolidated balance sheet. Such reclassification did not have any impact on the total liabilities owed by the Company as of March 31, 2024. Management has evaluated this change and concluded it was material to the prior period. Therefore, the Company is restating the previously issued unaudited financial statements, and related notes thereto, as of March 31, 2024.

 

The impact of the errors described above on the condensed consolidated balance sheet as of March 31, 2024, is as follows:

 

   As Previously Reported   Adjustment   As Restated 
   As of March 31, 2024 
(Dollar amounts in thousands) 

As

Previously

Reported

   Adjustment   As Restated 
Condensed Consolidated Balance               
Current liabilities               
Deferred commission payable   -    5,738    5,738 
Total current liabilities   1,984    5,738    7,722 
Deferred commission payable   5,738    (5,738)   - 
Total liabilities   8,016    -    8,016 

 

Revision of Previously Issued Financials Statements: March 31, 2023

 

In connection with the preparation of the Company’s financial statements as of and for the year ended December 31, 2023, the Company’s management identified errors in its previously issued unaudited financial statements as of and for the three months ended March 31, 2023 with respect to how certain expenses relating to the Merger were previously expensed and that as part of the Company’s annual audit it was determined that such expenses should have been capitalized and subsequently recorded against equity and restated such quarterly period in the December 31, 2023 Form 10-K. The accounting for legal costs was deemed to be specific incremental costs directly attributable to the Merger and concurrent PIPE financing (See Note 3). Management has evaluated this correction to the accounting treatment of such costs, which overstated net loss, additional paid in capital, and accumulated deficit and understated prepaid expense, and concluded it was material to the prior quarterly periods, individually and in the aggregate.

 

 

The impact of the errors described above on the balance sheet as of March 31, 2023, is as follows (in thousands):

 

   As Previously Reported   Adjustment   As Restated 
   As of March 31, 2023 (Unaudited) 
   As Previously Reported   Adjustment   As Revised 
Balance Sheets (in thousands)               
Assets               
Current assets               
Prepaid expenses and other current assets  $-   $493   $493 
Total current assets   8    493    501 
Total assets   13    493    506 
Stockholders’ deficit               
Accumulated deficit   (12,929)   493    (12,436)
Total shareholders’ deficit   (12,517)   493    (12,024)
Total liabilities and shareholders’ deficit  $13   $493   $506 

 

The impact of the errors described above on the statements of operations and comprehensive loss for the three months ended March 31, 2023, is as follows (in thousands):

 

   As  Previously Reported   Adjustment   As Restated 
   For the three months ended March 31, 2023 (Unaudited) 
   As  Previously Reported   Adjustment   As Revised 
Statements of Operations and Comprehensive Loss (in thousands)               
Operating expenses:               
General and administrative expenses  $2,008   $(493)  $1,515 
Total operating costs and expenses   2,008    (493)   1,515 
Operating loss   (2,008)   493    (1,515)
Net loss  $(2,165)  $493   $(1,672)
Net loss per share attributable to ordinary shareholders – basic and diluted*  $(1,082)  $247   $(835)
Total Comprehensive Loss  $(2,428)  $493   $(1,935)

 

*Does not reflect the impact of the Merger on the Company’s capital structure

 

The impact of the errors described above on the statements of changes in shareholders’ deficit as of March 31, 2023, is as follows (in thousands):

 

   As  Previously Reported   Adjustment   As Restated 
   As of March 31, 2023 (Unaudited) 
   As  Previously Reported   Adjustment   As Revised 
Statements of Changes in Shareholders’ Deficit (in thousands)               
Accumulated deficit  $(12,929)  $493   $(12,436)
Total shareholders’ deficit  $(12,517)  $493   $(12,024)

 

 

The impact of the errors described above on the statements of cash flows for the three months ended March 31, 2023, is as follows (in thousands):

 

   As  Previously Reported   Adjustment   As Restated 
   For the three months ended March 31, 2023 (Unaudited) 
   As  Previously Reported   Adjustment   As Revised 
Statements of Cash Flows (in thousands)               
Cash flows from operating activities:               
Net loss  $(2,165)   493    (1,672)
Changes in operating assets and liabilities:               
Prepaid expenses and other current assets  $-    (493)   (493)